TY - JOUR
T1 - Demographics, Care Patterns, and Outcomes of Patients Admitted to Cardiac Intensive Care Units
T2 - The Critical Care Cardiology Trials Network Prospective North American Multicenter Registry of Cardiac Critical Illness
AU - Bohula, Erin A.
AU - Katz, Jason N.
AU - Van Diepen, Sean
AU - Alviar, Carlos L.
AU - Baird-Zars, Vivian M.
AU - Park, Jeong Gun
AU - Barnett, Christopher F.
AU - Bhattal, Gurjaspreet
AU - Barsness, Gregory W.
AU - Burke, James A.
AU - Cremer, Paul C.
AU - Cruz, Jennifer
AU - Daniels, Lori B.
AU - Defilippis, Andrew
AU - Granger, Christopher B.
AU - Hollenberg, Steven
AU - Horowitz, James M.
AU - Keller, Norma
AU - Kontos, Michael C.
AU - Lawler, Patrick R.
AU - Menon, Venu
AU - Metkus, Thomas S.
AU - Ng, Jason
AU - Orgel, Ryan
AU - Overgaard, Christopher B.
AU - Phreaner, Nicholas
AU - Roswell, Robert O.
AU - Schulman, Steven P.
AU - Snell, R. Jeffrey
AU - Solomon, Michael A.
AU - Ternus, Bradley
AU - Tymchak, Wayne
AU - Vikram, Fnu
AU - Morrow, David A.
N1 - Funding Information:
reported personal fees from BestDoctors Inc and Oakstone-EBIX and royalties from McGraw-Hill publishing outside the submitted work. Dr Tymchak reported honoraria from Bayer and consulting fees from Amgen, Bayer, and Merck. Dr Solomon receives research support from National Institutes of Health Clinical Center intramural research funds. No other disclosures were reported. Critical Care Cardiology Trials Network (CCCTN): Executive committee: David A. Morrow, MD, MPH (Brigham and Women’s Hospital), Jason N. Katz, MD, MHS (University of Chapel Hill), and Sean van Diepen, MD, MSc (University of Alberta); steering committee: Gregory W. Barsness, MD (Mayo Clinic), Christopher B. Granger, MD (Duke University), Steven M. Hollenberg, MD (Cooper University Hospital), James D. Horowitz, MD (New York University Langone Health), Venu Menon, MD (Cleveland Clinic Foundation), Robert O. Roswell, MD (New York University Langone Health), and Michael A. Solomon, MD (National Heart, Lung, and Blood Institute); CCCTN data coordinating center (TIMI Study Group, Brigham and Women’s Hospital): Marc S. Sabatine, MD, MPH, Erin A. Bohula, MD, DPhil, Vivian Baird-Zars, MPH, Abby Cange, and Sabina A. Murphy; collaborating enrolling centers: D. Silva, RN, BSN, MPH (Brigham and Women’s Hospital); Paul C. Cremer, MD, Aldo Schenone, MD, K. Rutkowski, RN (Cleveland Clinic Foundation); Jennifer Cruz, DO, Daniel Ricketti, MD, and John Trujillo, MD (Cooper University Hospital); Steven Schulman, MD, Thomas S. Metkus, MD, Khalil Ibrahim, MD, and Faisal Rahman, MD (Johns Hopkins Hospital); James A. Burke, MD, Fnu Vikram, MD, and Kristen Cornell, RN, BSN (Research Coordinator) (Lehigh Valley Health Network); Jacob C. Jentzer, MD, and Bradley Ternus, MD (Mayo Clinic, Rochester); Christopher F. Barnett, MD, S. Ahmed, RN, L. Barrett, RN, and Shreejana Pokharel, MPH (Medstar Washington Hospital Center); Norma Keller, MD, and J. Ng, MD (New York University Langone Health); R. Jeffrey Snell, MD, Issam Atallah, MD, Nusrat Jahan, MBBS, MPH, and K. Jones, RN, MSN (Rush University Medical Center); Patrick R. Lawler, MD, MPH, and K. Tsang, RN, BScN, MN (Toronto General Hospital); Sean van Diepen, MD, MSc, Wayne Tymchak, MD, and N. Hogg, RN (University of Alberta); Carlos L. Alviar, MD, Gurjaspreet Bhattal, MD, Nathan Gargus, MD, Dana D. Leach, DNP, ARNP-C, S. Long, RN, BSN, J. Bostick, and M. Mohammed (University of Florida); Llori B. Daniels, MD, Nicholas Phreaner, MD, Paula Anzenberg, BS, Caitlyn Belza, Taelor Getz, BS, J. Gonzalez, J. Marsal, R. Sedighi, Avinash Toomu, BS, and S. Toomu (University of California, San Diego); Andrew DeFilippis, MD, and S. Vincent, MSN, RN (University of Louisville); Cristie Dangerfield, MSN, RN, CNL, CCRN-K, Ryan Orgel, MD, Z. Ozen, RN, E. Prosser, RN, and T. Wade (University of North Carolina, Chapel Hill); and Michael C. Kontos, MD, S. Dow, MD, and Chau Vo, MD (Virginia Commonwealth University).
Publisher Copyright:
© 2019 American Medical Association. All rights reserved.
PY - 2019/9
Y1 - 2019/9
N2 - Importance: Single-center and claims-based studies have described substantial changes in the landscape of care in the cardiac intensive care unit (CICU). Professional societies have recommended research to guide evidence-based CICU redesigns. Objective: To characterize patients admitted to contemporary, advanced CICUs. Design, Setting, and Participants: This study established the Critical Care Cardiology Trials Network (CCCTN), an investigator-initiated multicenter network of 16 advanced, tertiary CICUs in the United States and Canada. For 2 months in each CICU, data for consecutive admissions were submitted to the central data coordinating center (TIMI Study Group). The data were collected and analyzed between September 2017 and 2018. Main Outcomes and Measures: Demographics, diagnoses, management, and outcomes. Results: Of 3049 participants, 1132 (37.1%) were women, 797 (31.4%) were individuals of color, and the median age was 65 years (25th and 75th percentiles, 55-75 years). Between September 2017 and September 2018, 3310 admissions were included, among which 2557 (77.3%) were for primary cardiac problems, 337 (10.2%) for postprocedural care, 253 (7.7%) for mixed general and cardiac problems, and 163 (4.9%) for overflow from general medical ICUs. When restricted to the initial 2 months of medical CICU admissions for each site, the primary analysis population included 3049 admissions with a high burden of noncardiovascular comorbidities. The top 2 CICU admission diagnoses were acute coronary syndrome (969 [31.8%]) and heart failure (567 [18.6%]); however, the proportion of acute coronary syndrome was highly variable across centers (15%-57%). The primary indications for CICU care included respiratory insufficiency (814 [26.7%]), shock (643 [21.1%]), unstable arrhythmia (521 [17.1%]), and cardiac arrest (265 [8.7%]). Advanced CICU therapies or monitoring were required for 1776 patients (58.2%), including intravenous vasoactive medications (1105 [36.2%]), invasive hemodynamic monitoring (938 [30.8%]), and mechanical ventilation (652 [21.4%]). The overall CICU mortality rate was 8.3% (95% CI, 7.3%-9.3%). The CICU indications that were associated with the highest mortality rates were cardiac arrest (101 [38.1%]), cardiogenic shock (140 [30.6%]), and the need for renal replacement therapy (51 [34.5%]). Notably, patients admitted solely for postprocedural observation or frequent monitoring had a mortality rate of 0.2% to 0.4%. Conclusions and Relevance: In a contemporary network of tertiary care CICUs, respiratory failure and shock predominated indications for admission and carried a poor prognosis. While patterns of practice varied considerably between centers, a substantial, low-risk population was identified. Multicenter collaborative networks, such as the CCCTN, could be used to help redesign cardiac critical care and to test new therapeutic strategies.
AB - Importance: Single-center and claims-based studies have described substantial changes in the landscape of care in the cardiac intensive care unit (CICU). Professional societies have recommended research to guide evidence-based CICU redesigns. Objective: To characterize patients admitted to contemporary, advanced CICUs. Design, Setting, and Participants: This study established the Critical Care Cardiology Trials Network (CCCTN), an investigator-initiated multicenter network of 16 advanced, tertiary CICUs in the United States and Canada. For 2 months in each CICU, data for consecutive admissions were submitted to the central data coordinating center (TIMI Study Group). The data were collected and analyzed between September 2017 and 2018. Main Outcomes and Measures: Demographics, diagnoses, management, and outcomes. Results: Of 3049 participants, 1132 (37.1%) were women, 797 (31.4%) were individuals of color, and the median age was 65 years (25th and 75th percentiles, 55-75 years). Between September 2017 and September 2018, 3310 admissions were included, among which 2557 (77.3%) were for primary cardiac problems, 337 (10.2%) for postprocedural care, 253 (7.7%) for mixed general and cardiac problems, and 163 (4.9%) for overflow from general medical ICUs. When restricted to the initial 2 months of medical CICU admissions for each site, the primary analysis population included 3049 admissions with a high burden of noncardiovascular comorbidities. The top 2 CICU admission diagnoses were acute coronary syndrome (969 [31.8%]) and heart failure (567 [18.6%]); however, the proportion of acute coronary syndrome was highly variable across centers (15%-57%). The primary indications for CICU care included respiratory insufficiency (814 [26.7%]), shock (643 [21.1%]), unstable arrhythmia (521 [17.1%]), and cardiac arrest (265 [8.7%]). Advanced CICU therapies or monitoring were required for 1776 patients (58.2%), including intravenous vasoactive medications (1105 [36.2%]), invasive hemodynamic monitoring (938 [30.8%]), and mechanical ventilation (652 [21.4%]). The overall CICU mortality rate was 8.3% (95% CI, 7.3%-9.3%). The CICU indications that were associated with the highest mortality rates were cardiac arrest (101 [38.1%]), cardiogenic shock (140 [30.6%]), and the need for renal replacement therapy (51 [34.5%]). Notably, patients admitted solely for postprocedural observation or frequent monitoring had a mortality rate of 0.2% to 0.4%. Conclusions and Relevance: In a contemporary network of tertiary care CICUs, respiratory failure and shock predominated indications for admission and carried a poor prognosis. While patterns of practice varied considerably between centers, a substantial, low-risk population was identified. Multicenter collaborative networks, such as the CCCTN, could be used to help redesign cardiac critical care and to test new therapeutic strategies.
UR - http://www.scopus.com/inward/record.url?scp=85069658148&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85069658148&partnerID=8YFLogxK
U2 - 10.1001/jamacardio.2019.2467
DO - 10.1001/jamacardio.2019.2467
M3 - Article
C2 - 31339509
AN - SCOPUS:85069658148
SN - 2380-6583
VL - 4
SP - 928
EP - 935
JO - JAMA cardiology
JF - JAMA cardiology
IS - 9
ER -